RUPALI JATIN's Insider Trades & SAST Disclosures

Visit FAQs

RUPALI JATIN's most recent trade in Strides Pharma Science Ltd. was a Acquisition of 5,014 Equity Shares done at an average price of Rs. 475 . Disclosure was reported to the exchange on Dec. 4, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for RUPALI JATIN in the Trendlyne database.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Strides Pharma
RUPALI JATIN Promoter Group Acquisition 04 Dec 2020 5,014 189,826 (0.21%) 0.01% 475 2,381,650 01 Dec 2020
03 Dec 2020		 Insider Trading Equity Shares Off Market
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST